Giavarina D, Carta M. Determination of reference interval for PSP, an early marker for sepsis. *Biochemical Medicine (Zagreb. 25:64–8.
2.
Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A, et al. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: Data from the multicenter, randomized ALBIOS trial. *Intensive Care Medicine. 41:12–20.
3.
Nagata T, Yasuda Y, Ando M, Abe T, Katsuno T, Kato S, et al. Clinical impact of kidney function on presepsin levels. *PLoS One. 10:0129159.
4.
Chenevier-Gobeaux C, Trabattoni E, Roelens M, Borderie D, Claessens YE. Presepsin (sCD14-ST) in emergency department: The need for adapted threshold values? *Clinical Chimica Acta. 427:34–6.
5.
Kotera A, Sagishima K, Tashiro T, Niimori D, Kamohara H, Kinoshita Y. A validation of presepsin levels in kidney dysfunction patients: Four case reports. *Journal of Intensive Care. 2:63.
6.
Honore PM, Jacobs R, Hendrickx I, Waele E, Gorp V, Spapen HD. Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: Will another promising biomarker bite the dust? *Critical Care. 19:428.
7.
Nakamura Y, Ishikura H, Nishida T, Kawano Y, Yuge R, Ichiki R, et al. Usefulness of presepsin in diagnosis of sepsis in patients with or without acute kidney injury. *BMC Anesthesiology. 14:88.
Claessens YE, Trabattoni E, Grabar S, Quinquis L, Sahakian G, Anselmo M, et al. Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patients. *Clinical Chimica Acta. 464:182–8.
10.
Wu CC, Lan HM, Han ST, Chaou CH, Yeh CF, Liu SH, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: A systematic review and meta-analysis. *Annals of Intensive Care. 7:91.
11.
Liu Y, Hou JH, Li Q, Chen KJ, Wang SN, Wang JM. Biomarkers for diagnosis of sepsis in patients with SIRS: A systematic review and meta-analysis. *SpringerPlus. 5.
12.
Ulla M, Pizzolato E, Lucchiari M, Loiacono M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: A multicenter prospective study. *Critical Care. 17:168.
13.
Zanoni I, Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. *Frontiers in Cellular and Infection Microbiology. 3:32.
14.
Zheng Z, Jiang L, Ye L, Gao Y, Tang L, Zhang M. The accuracy of PSP for the diagnosis of sepsis from SIRS: A systematic review and meta-analysis. *Annals of Intensive Care. 5:48.
15.
Jacobs L, Wong HR. Emerging infection and sepsis biomarkers: Will they change current therapies? *Expert Review of Anti-Infective Therapy. 14:929–41.
16.
Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. *Journal of Infectious Chemotherapy. 17:764–9.
17.
Volanakis JE. Human C-reactive protein: Expression, structure, and function. *Molecular Immunology. 38:189–97.
18.
Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST. *Clinical Chimica Acta. 412:2157–61.
19.
Chenevier-Gobeaux C, Bardet V, Poupet H, Poyart C, Borderie D, Claessens YE. Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line. *Annals of Biology and Clinical (Paris. 74*(1:93–7.
20.
Qi Z, Wei W, Zhang XC. Presepsin as a novel sepsis biomarker. *World Journal of Emergency Medicine. 5:16–9.
21.
Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: New clinical and analytical perspectives for two old biomarkers. *Journal of Matern-Fetal and Neonatal Medicine. Suppl 2:12–4.
22.
Zhang J, Hu ZD, Song J, Shao J. Diagnostic value of presepsin for sepsis. *Medicine (Baltimore. 94*(47:2158.
23.
Meuleman P, Steyaert S, Libbrecht L, Couvent S, Houtte F, Clinckspoor F, et al. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection. *Clinical Chimica Acta. 366:156–62.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
